Matinas BioPharma Holdings Inc.

About Matinas BioPharma Holdings Inc.

Matinas BioPharma Holdings, Inc. is a biopharmaceutical company focused on improving the intracellular delivery of important therapeutics through its proprietary Lipid Nano-Crystal (LNC) platform. The company aims to safely deliver a broad range of potent medicines orally, targeting areas such as oncology and inflammation.

Products & Services

LNC Platform:A proprietary intracellular platform designed to safely deliver a broad range of potent medicines, including small molecules and small oligonucleotides, orally.

MAT2203:An oral and non-toxic encochleated form of amphotericin B, developed using LNC technology, aimed at providing a potent and safe treatment.

Specialties

Lipid Nano-Crystal (LNC) Technology Intracellular Drug Delivery Oral Drug Delivery Oncology Inflammation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2024-04-03 FD: 2024-04-03	1 investors

Registered Direct Offering Latest

2024-04-03

$10.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Robin L. Smith

Director

E

Evelyn D'An

Director

M

Mannino

D

David Perlin

Dr.

J

Jerome D. Jabbour

Co-founder, Chairman & Chief Executive Officer

K

Keith A. Kucinski

Chief Financial Officer

View 9 more team members with Pro

Unlock Full Team Directory

Recent News